GSA Capital Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
GSA Capital Partners's ASND Position: Q3 2026 in Review
GSA Capital Partners sold out of Ascendis Pharma (ASND) in Q3 2026, closing a stake of 1,071 shares — an estimated $286K sold.
GSA Capital Partners first reported a position in ASND in Q1 2016 and held it in 8 quarters. The position peaked at $1.1M in Q4 2021. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- GSA Capital Partners reported no remaining Ascendis Pharma position as of Q3 2026 after selling out during the quarter.
- GSA Capital Partners sold 1,071 Ascendis Pharma shares in Q3 2026, an estimated $286K.
- GSA Capital Partners first reported a position in Ascendis Pharma in Q1 2016 and held it in 8 quarters.
- GSA Capital Partners's Ascendis Pharma position peaked at $1.1M in Q4 2021.
- 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.